Transcutaneous immunization using a dissolving microneedle array protects against tetanus, diphtheria, malaria, and...

Area of Science:

• Immunology
• Vaccinology
• Biomaterials Science

Background:

• Transcutaneous immunization (TCI) presents a less invasive alternative to traditional injection vaccination methods.
• A previously developed dissolving microneedle array for TCI demonstrated immune response induction against model antigens.

Purpose of the Study:

• To evaluate the efficacy of the dissolving microneedle TCI system against tetanus, diphtheria, malaria, and influenza.
• To assess the potential of TCI as a viable vaccination strategy for infectious diseases.

Main Methods:

• Utilized a dissolving microneedle array for transcutaneous immunization in a preclinical setting.
• Administered vaccines targeting tetanus and diphtheria toxoids, malaria antigens, and influenza hemagglutinin (HA).
• Measured toxoid-specific IgG levels, toxin-neutralizing antibody titers, anti-parasite antibodies, and protective immunity against influenza challenge.

Main Results:

• TCI with the microneedle array induced significant increases in toxoid-specific IgG and toxin-neutralizing antibodies.
• The system elicited anti-SE36 IgG production, capable of binding to malaria parasites.
• Influenza HA vaccination via TCI resulted in robust antibody production and complete protection against viral challenge in mice.

Conclusions:

• Dissolving microneedle-based TCI effectively elicits substantial immune responses against multiple infectious diseases.
• This TCI technology shows promise for developing needle-free vaccines against significant global health threats.
• Translational research for human clinical trials is underway based on these promising preclinical findings.